The Global Ornidazole Market was valued at USD 218.5 Million in 2024 and is projected to reach USD 298.7 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period (2024–2030). This consistent growth is primarily driven by the increasing global prevalence of protozoal infections such as amoebiasis and giardiasis, rising awareness of parasitic diseases in developing nations, and the expanding use of Ornidazole in both human and veterinary medicine.

As the healthcare sector intensifies its focus on combating parasitic infections through effective and accessible treatments, the role of key pharmaceutical manufacturers becomes paramount. In this blog, we profile the Top 10 Companies in the Ornidazole Industry—a mix of established API manufacturers, specialty pharma players, and global suppliers shaping the supply chain for this critical antiparasitic drug.

---

🔟 1. Suyash Laboratories Ltd.

Headquarters: Hyderabad, Telangana, India
Key Offering: Ornidazole API (Active Pharmaceutical Ingredient), Ornidazole Tablets

Suyash Laboratories is a prominent Indian pharmaceutical company with a strong focus on API manufacturing. It is a leading supplier of high-purity Ornidazole, catering to both domestic formulation companies and international markets. The company’s vertically integrated operations ensure stringent quality control from raw material sourcing to finished product.

Research & Development Initiatives:

• Investment in advanced synthesis and purification technologies for APIs
• Development of novel drug delivery systems for antiparasitic drugs
• Focus on scaling up production capacity to meet rising global demand

Download FREE Sample Report:
Ornidazole Market – View in Detailed Research Report

---

9️⃣ 2. Endoc Pharma

Headquarters: Ahmedabad, Gujarat, India
Key Offering: Ornidazole API, Finished Dosage Forms (Tablets, Injections)

Endoc Pharma specializes in the manufacturing and marketing of APIs and formulations, with Ornidazole being a key product in its portfolio. The company serves a wide network of clients across Asia, Africa, and Latin America, focusing on quality and affordability in therapeutic segments like anti-infectives and gastroenterology.

Research & Development Initiatives:

• Continuous process optimization for cost-effective API production
• Expansion of regulatory approvals in emerging markets
• Development of combination therapies involving Ornidazole

---

8️⃣ 3. Lasa Laboratory Pvt. Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Ornidazole API, Veterinary Ornidazole Products

Lasa Laboratory is a well-established player in the bulk drug industry, known for its robust manufacturing capabilities for nitroimidazole compounds. The company has a significant export footprint and supplies Ornidazole to pharmaceutical companies worldwide for human and veterinary applications.

Research & Development Initiatives:

• Specialization in the nitroimidazole class of compounds
• Strengthening compliance with international quality standards (WHO-GMP, USFDA)
• Exploring new applications for Ornidazole in niche therapeutic areas

---

7️⃣ 4. Supor Group

Headquarters: Shanghai, China
Key Offering: Ornidazole API, Pharmaceutical Intermediates

Supor Group is one of China’s major chemical and pharmaceutical enterprises, with a diversified portfolio that includes Ornidazole. The company leverages its large-scale chemical synthesis expertise to produce cost-competitive APIs for the global market, playing a crucial role in the supply chain.

Research & Development Initiatives:

• Large-scale, integrated chemical production facilities
• Focus on environmental sustainability in manufacturing processes
• Strategic partnerships with global pharmaceutical distributors

Download FREE Sample Report:
Ornidazole Market – View in Detailed Research Report

---

6️⃣ 5. Nanjing Sanhome Pharmaceutical Co., Ltd.

Headquarters: Nanjing, Jiangsu, China
Key Offering: Ornidazole API, Ornidazole Tablets, Capsules, and Injections

Nanjing Sanhome is a leading Chinese pharmaceutical company engaged in the R&D, production, and sale of pharmaceutical products. It offers a comprehensive range of Ornidazole-based formulations and is actively expanding its presence in international markets through strategic exports.

Research & Development Initiatives:

• Strong in-house R&D capabilities for drug development
• Portfolio expansion in anti-infective and gastrointestinal drugs
• Investment in modern GMP-certified manufacturing plants

---

5️⃣ 6. Huadong Medicine Co., Ltd. (Bodyguard Pharmaceutical)

Headquarters: Hangzhou, Zhejiang, China
Key Offering: Ornidazole API, Finished Dosage Forms

Huadong Medicine, through its subsidiary Bodyguard Pharmaceutical, is a major force in the Chinese pharmaceutical market. The company has a diverse product portfolio and manufactures Ornidazole, distributing it extensively within China and for export, backed by a strong distribution network.

Research & Development Initiatives:

• Comprehensive product pipeline including generic drugs
• Emphasis on quality control and regulatory affairs
• Integration of digital platforms for supply chain management

---

4️⃣ 7. Hunan Jiudian Pharmaceutical Co., Ltd.

Headquarters: Changsha, Hunan, China
Key Offering: Ornidazole API, Pharmaceutical Formulations

Hunan Jiudian is a specialized pharmaceutical manufacturer with a focus on APIs and finished formulations. The company is a key supplier of Ornidazole and other chemical drugs, with a commitment to innovation and quality that serves both the domestic and international healthcare sectors.

Research & Development Initiatives:

• Dedicated R&D center for process improvement and new drug development
• Expansion of production lines to increase API output
• Focus on entering regulated markets with high-quality dossiers

---

3️⃣ 8. Zhejiang Charioteer Pharmaceutical Co., Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Ornidazole API, Custom Synthesis

Zhejiang Charioteer is a growing API manufacturer known for its technical expertise in chemical synthesis. The company produces Ornidazole and offers custom manufacturing services, positioning itself as a reliable partner for pharmaceutical companies seeking quality bulk drugs.

Research & Development Initiatives:

• Specialization in niche APIs and advanced intermediates
• Investment in green chemistry initiatives
• Building a robust quality management system for global compliance

---

2️⃣ 9. Taj Pharmaceuticals Limited

Headquarters: Mumbai, Maharashtra, India
Key Offering: Ornidazole Tablets, Ornidazole API

Taj Pharmaceuticals is a globally recognized name with a significant presence in the generic pharmaceuticals space. The company manufactures and markets a wide range of drugs, including Ornidazole formulations, and has a substantial distribution network across Africa, Asia, and the Middle East.

Research & Development Initiatives:

• Global regulatory strategy for product registrations
• Focus on affordable medicine for emerging economies
• Development of patient-centric drug formats

---

1️⃣ 10. Salius Pharma Pvt. Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Ornidazole Tablets, Ornidazole Injection

Salius Pharma is a specialized pharmaceutical company focused on critical care and essential medicine segments. It is a key supplier of Ornidazole in finished dosage forms, ensuring access to this vital antiparasitic drug in hospital and retail pharmacy channels.

Research & Development Initiatives:

• Portfolio strengthening in the anti-infective therapeutic area
• Strategic focus on institutional sales and government tenders
• Commitment to maintaining high pharmacopoeial standards

Get Full Report Here:
Ornidazole Market – View in Detailed Research Report

---

🌍 Outlook: The Future of the Ornidazole Market is Driven by Accessibility and Innovation

The Ornidazole market is experiencing steady evolution. While generic competition is intensifying, the industry is focusing on improved formulations, combination therapies, and expanding access in underserved regions to drive future growth.

📈 Key Trends Shaping the Market:

• Increasing adoption of Fixed-Dose Combinations (FDCs) with Ornidazole for broader-spectrum treatment
• Growing demand in veterinary medicine for parasitic infections in livestock and pets
• Rising healthcare expenditure and improving diagnostic rates in emerging economies
• Stringent regulatory standards pushing manufacturers toward higher quality and compliance

Get Full Report Here:
Ornidazole Market – View in Detailed Research Report

The companies listed above are not only supplying a critical therapeutic agent—they are central to the global fight against parasitic diseases, ensuring that effective treatments remain available and affordable for patients worldwide.